Showing 10,501 - 10,520 results of 10,572 for search '"Tumor"', query time: 0.09s Refine Results
  1. 10501

    Aspergilosis invasiva con compromiso óseo en lactante de cuatro meses con enfermedad granulomatosa crónica by Héctor Gómez-Tello, Estefany Graciela Mamani-Velásquez, Ana Karen Gómez-Gutiérrez, Carlos Sánchez-Flores, Virginia Lora-Téllez, Sara Espinosa-Padilla, Lizbeth Blancas-Galicia

    Published 2024-12-01
    “…Se trata de un lactante de sexo masculino de cuatro meses de edad, de madre hipotiroidea y con quien convive en la celda de la cárcel. El infante presentó tumores en la región axilar izquierda y la radiografía de tórax sugirió fracturas costales; fue hospitalizado ante la sospecha de maltrato infantil. …”
    Get full text
    Article
  2. 10502

    Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis by Meng Wang, Xing Huang, Tingbo Liang, Tianyu Tang, Gang Zhang, Minghao Lu, Zhengtao Hong, Junming Huang, Xiao Zhi

    Published 2022-03-01
    “…Both in-house tissue microarray and open accessed The Cancer Genome Atlas data sets were used to evaluate the clinical relevance in pancreatic cancer prognosis.Results LTX-315 treatment inhibited PD-L1 expression and enhanced lymphocyte infiltration in pancreatic tumors. ATP11B was identified as a potential target of LTX-315 and a critical regulator in maintaining PD-L1 expression in pancreatic cancer cells. …”
    Get full text
    Article
  3. 10503

    Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer by Shuwen Dong, Anqi Li, Ruixin Pan, Jin Hong, Zheng Wang, Kunwei Shen

    Published 2025-01-01
    “…IntroductionBreast cancer is among the most prevalent malignant tumors globally, with carboplatin serving as a standard treatment option. …”
    Get full text
    Article
  4. 10504

    Effects of Clinicopathological Characteristics on the Survival of Patients Treated with PD-1/PD-L1 Inhibitor Monotherapy or Combination Therapy for Advanced Cancer: A Systemic Revi... by Yuhan Wei, Yongfu Li, Qi Du, Xinyi Peng, Jiangtao Jin, Hong Guo, Yongyan Li, Qin Li

    Published 2020-01-01
    “…Both PD-1/PD-L1 inhibitor monotherapy and combination therapy significantly prolonged the OS of patients with advanced malignant tumors. EGFR status for monotherapy and sex and smoking status for combination therapy were important predictors of survival benefits.…”
    Get full text
    Article
  5. 10505

    Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis by Jie Dai, Tianxiao Xu, Lifeng Li, Meiyu Fang, Jing Lin, Jun Cao, Xue Bai, Caili Li, Xiaoting Wei, Junjie Gu, Yaoyao Liu, Xuan Gao, Xuefeng Xia, Jun Guo, Yu Chen, Lili Mao, Lu Si

    Published 2025-01-01
    “…Key points 3‐year follow‐up study confirmed the therapeutic efficacy of atezolizumab combined with bevacizumab Tumors in the upper site and NRAS mutations are more sensitive to treatment Inflammatory cell infiltration, angiogenic status, and activation of the SMAD2 and p38 MAPK pathways may be prognostic indicators…”
    Get full text
    Article
  6. 10506

    Algunas consideraciones en torno al cáncer de esófago by José Antonio Suárez Rodríguez, Ana María Nazario Dolz, Lázaro Ibrahim Romero García, Gilberto Carlos Falcón Vilariño, Grethel Odalys Rivero Reyes

    Published 2022-06-01
    “…El carcinoma epidermoide y el adenocarcinoma representan el 95,0 % de todos los tumores esofágicos. La esofagectomía abierta o mínimamente invasiva constituye el pilar básico del tratamiento quirúrgico. …”
    Get full text
    Article
  7. 10507

    BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia by Xu Sang, Yongping Zhang, Fang Fang, Li Gao, Yanfang Tao, Xiaolu Li, Zimu Zhang, Jianwei Wang, Yuanyuan Tian, Zhiheng Li, Di Yao, Yumeng Wu, Xinran Chu, Kunlong Zhang, Li Ma, Lihui Lu, Yanling Chen, Juanjuan Yu, Ran Zhuo, Shuiyan Wu, Zhen Zhang, Jian Pan, Shaoyan Hu

    Published 2022-01-01
    “…Recent studies have shown that as a novel BRD4 (bromodomain containing 4) PROTACs (proteolysis targeting chimeras) degrader, GNE-987 can slow down the growth of various tumors and increase apoptosis, with promising clinical prospects. …”
    Get full text
    Article
  8. 10508

    Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a... by Carole Fournier, Marion Mercey-Ressejac, Valentin Derangère, Amal Al Kadi, David Rageot, Christine Charrat, Alexis Leroy, Julien Vollaire, Véronique Josserand, Marie Escudé, Séverine Escaich, François Ghiringhelli, Thomas Decaens, Fabrice P. Navarro, Evelyne Jouvin-Marche, Patrice N. Marche

    Published 2025-02-01
    “…Methods: We evaluated whether NLC OVA mRNA complexes activate dendritic cells (DCs) in vitro and identified the involved signalling pathways using specific inhibitors. We tested the anti-tumoral impact of Ova mRNA vaccine in B16-OVA and E.G7-OVA cold tumour-bearing C57Bl6 female mice as well as its synergy effect with an anti-PD-1 therapy by following the tumour growth and performing immunophenotyping of innate and adaptive immune cells. …”
    Get full text
    Article
  9. 10509

    Cloning and Functional Analysis of <i>BraTSD2</i> Associated with Root Swelling in Turnip (<i>Brassica rapa</i> L.) by Wenyue Huang, Shifan Zhang, Fei Li, Hui Zhang, Rifei Sun, Guoliang Li, Shujiang Zhang

    Published 2025-01-01
    “…In this study, we cloned the turnip root swelling-related gene <i>BraTSD2</i> (<i>TUMOROUS SHOOT DEVELOPMENT 2</i>) and performed a preliminary functional analysis. …”
    Get full text
    Article
  10. 10510

    Relationship between gender and perioperative clinical features in lung cancer patients who underwent VATS lobectomy by Wei Chen, Qiangqiang Zheng, Yi Shen, Min Liang, Yang Yuan, Yusong Lu, Yunfeng Zhou

    Published 2024-12-01
    “…Conclusions Compared with female patients, male patients with lung cancer are more likely to have unfavorable factors such as older age, higher smoking rate, poor pulmonary function and late clinical stage of tumors when they undergoing VATS surgery treatment. …”
    Get full text
    Article
  11. 10511

    Heat shock transcription factor 1 facilitates liver cancer progression by driving super‐enhancer‐mediated transcription of MYCN by Yizhe Liu, Qili Shi, Yue Su, Zhiao Chen, Xianghuo He

    Published 2024-09-01
    “…Moreover, increased MYCN expression was detected in HCC tumors and correlated with unfavorable patient outcomes. …”
    Get full text
    Article
  12. 10512

    Lymphoadenopathies caused by Bartonella henselae by V.S. Zhukovskiy, O.V. Prokopiv, I.R. Trutyak, M.V. Pankiv

    Published 2023-12-01
    “…Often the disease is undiagnosed, mimicking lymphadenopathies caused by tumors of soft tissues and bones or other bacterial pathogens. …”
    Get full text
    Article
  13. 10513

    Neuropsychological features of patients of reproductive age diagnosed with breast cancer at the stage of surgical treatment using xenon-oxygen therapy by D. A. Rozenko, A. I. Shikhlyarova, L. N. Vaschenko, N. N. Popova, Yu. Yu. Arapova, A. Yu. Ardzha, A. A. Korobov

    Published 2021-09-01
    “…This study included 60 reproductive age patients with newly diagnosed breast cancer who were undergoing surgical treatment at the Department of Bone, Skin, Soft Tissue and Breast Tumors of the National Medical Research Centre for Oncology of the Ministry of Health of Russia from 2018 to 2020. …”
    Get full text
    Article
  14. 10514

    Recalcitrant Female Pattern Hair Loss Like Alopecia Unveils Unexpected Rare Entity by Nouh AH, Elgendy FM, Gobran FA, Zhuravlova MS

    Published 2025-01-01
    “…While MUHH mainly affects hair, it may also be linked to other conditions such as skin tumors (trichoepithelioma), limb abnormalities, eye issues, wide-spaced teeth, and syndromes like Ehlers-Danlos or atopy.Because MUHH is so rare, diagnosing it can be difficult, and many healthcare providers may not immediately recognize it. …”
    Get full text
    Article
  15. 10515

    Increased PD-1 expression in livers associated with PD-1-antibody-induced hepatotoxicity by Miro Saarela, Essi Parviainen, Ana Lleo, Luca di Tommaso, Hanna Raunio, Krista Kankaanranta, Katri Vuopala, Aino Rönkä, Sini Nurmenniemi, Raija Kallio, Arja Jukkola, Katri S. Selander

    Published 2025-01-01
    “…Notably, none of the cancer patients had primary nor metastatic liver tumors. We also studied direct growth effects of pembrolizumab on primary human intrahepatic biliary epithelial cells (HIBEpiC) in vitro. …”
    Get full text
    Article
  16. 10516

    Levels of growth factors in the lungs affected by cancer with preventive effect of 1,3-diethylbenzimidazolium triiodide in the experiment by E. M. Frantsiyants, I. V. Kaplieva, L. K. Trepitaki

    Published 2020-12-01
    “…Lung tissues of intact females showed 1.4 times (p&lt;0.05) lower VEGF-А and 3.3 times higher sVEGF-R1, compared to males. The development of tumors in all control rats was accompanied by the VEGF-А increase (by 1.6–3.0 times) and the TGF-β reduction (by 3 times). …”
    Get full text
    Article
  17. 10517

    Retrospective Analysis Comparing Lung-RADS v2022 and British Thoracic Society Guidelines for Differentiating Lung Metastases from Primary Lung Cancer by Loredana Gabriela Stana, Alexandru Ovidiu Mederle, Claudiu Avram, Felix Bratosin, Paula Irina Barata

    Published 2025-01-01
    “…<b>Results</b>: Of the 196 patients, 148 (75.5%) had de novo primary lung cancer, and 48 (24.5%) had lung metastases from occult primary tumors. Lung-RADS Version 2022 demonstrated higher specificity than BTS guidelines (87.2% vs. 72.3%, <i>p</i> < 0.001) while maintaining similar sensitivity (91.7% vs. 93.8%, <i>p</i> = 0.68) in differentiating lung metastases from primary lung cancer. …”
    Get full text
    Article
  18. 10518

    Robotic Assistance in Percutaneous Liver Ablation Therapies: A Systematic Review and Meta-Analysis by Ana K. Uribe Rivera, MD, Barbara Seeliger, MD, PhD, Laurent Goffin, MSc, Alain García-Vázquez, MD, Didier Mutter, MD, PhD, Mariano E. Giménez, MD, PhD

    Published 2024-06-01
    “…Robotic assistance in percutaneous ablation for liver tumors achieves superior results and reduces errors compared with manual applicator insertion. …”
    Get full text
    Article
  19. 10519
  20. 10520

    Clinical Features and Prognosis of Double-Positive Anti-MDA5 and Anti-CCP Antibodies in Dermatomyositis: A Retrospective Study by Xu X, Zhu L, Li S, Wang G, Ge Y

    Published 2025-02-01
    “…For MDA5+ DM patients with positive anti-CCP antibodies, thorough screening for tumors is crucial to guide treatment and improve prognosis.Keywords: dermatomyositis, anti-MDA5 antibody, anti-CCP antibody, rheumatoid arthritis, interstitial lung disease…”
    Get full text
    Article